Overview

The Efficacy and Safety of Qizhiweitong Granule on Patients With Functional Dyspepsia in a Multi-center Clinical Study

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The study aims to verify the efficacy and safety of Qizhiweitong granule on Chinese patients with functional dyspepsia diagnosed by the Rome III criteria. It includes two subtypes of functional dyspepsia, postprandial distress syndrome or abdominal pain syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Wuhan Union Hospital, China